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1. Introduction 
Amanitins are the slow acting toxic components of 
the poisonous mushroom Amanita phalloides [ 1 ] , 
which most probably cause the fatalities observed 
several days after ingestion of this toadstool. The struc- 
tural formula (Ia) of Q! -amanitin has been elucidated 
12, 31 as a cyclic octapeptide whose ring is divided by 
a sulfoxide bridge from an original cysteine sulfur to 
the 2-position of the indole nucleus of a tryptophan 
unit. Besides a-amanitin, which is a carboxamide, the 
corresponding carboxylic acid, f3-amanitin (Ib) has 
also been isolated. In the white mouse the toxicity of 
Ib is a little less than that of Ia, the LDsu being 0.3 
mg/kg body weight and 0.4 mg/kg respectively. The 
carboxylic group can be used as a handle for binding 
the toxin to various proteins, e.g. via thiophenylester 
[4] or carbodiimides [S] . 
2. Structure activity relationship 
Nature offers several examples for relationship of 
structure and toxicity. The &OH group in a side chain 
is not essential for the poisonous action for y-amanitin 
(Ic) is even more toxic (LDso = 0.15 mg/kg) than Ia. 
The phenolic hydroxyl in 6position also has no effect 
on toxicity: amanin (Id), which is devoid of it, has an 
amanitin-like action, as do the 6-methoxy derivatives 
of Ia, Ib and Ic obtained by reaction with diazomethane. 
Neither does the sulfoxide part of the molecule influen- 
ce toxicity, since the thioether prepared from 6-G 
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methyl-o-amanitin by treatment with Raney-nickel 
[6] was still toxic. Nontoxic variants of the mole- 
cule occur also in nature. Amanullin (Ie) is an ineffec- 
tual variant lacking only the -y-OH group in a side 
chain of y-amanitin (Ic) [7] , and the same is true 
for amanullic acid, the corresponding carboxylic com- 
pound [8]. The decisive y-OH can also be removed 
by oxidation (of 6Gmethyl+amanitin) with period- 
ate. The resulting aldehydic compound (“aldo-ama- 
nitin”) with a -CH(CH3)-CHO side chain, instead of 
-CH(CH,)-CH(OH)-CHlOH, shows no toxicity. 
Upon reduction with NaBH4 the side chain is trans- 
formed to the y-OH-containing -CH(CH,)-CH,OH 
with recovery of toxicity [9] . Destruction of the 
molecular shape by elimination of the SO-bridge or 
by opening one of the peptide bonds also results in 
disappearance of activity [l] . 
3. Symptoms of intoxication 
All laboratory animals except the rat are very sen- 
sitive to c+amanitin. The LDso on intraperitoneal in- 
jection is 0.2-0.3 mg/kg body weight in mice [ 11. 
The lethal doses for the guinea pig and the dog are 
0.05 mg/kg and 0.15 mg/kg respectively [ IO] , the rab- 
bit is also very sensitive but the lethal dose has not 
been determined. On the other hand the rat survives 
doses 10 times higher than those which kill the above 
mentioned animals [ lo] . In amphibians like frogs or 
toads sensitivity is much reduced, LDso being about 
15 mg/kg [Ill. 
In the mouse d-amanitin causes steatosis and necrosis 
of the liver and kidneys. In the adult male mouse one 
minimal lethal dose (MLD) of a-amanitin always pro- 
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duces necrosis of the kidneys but never of the liver; liv- 
er necrosis only appears with doses above MLD [ 121. 
Even after injection of 3 MLD, necrosis of the kid- 
neys never appears in less than 3 days; where there is 
necrosis of the liver it can result in death, before 
necrosis of the kidney has had time to develop. So in 
all mice given more than one MLD and dying within 2 
days there is necrosis of the liver, but not of the kid- 
neys [12]. 
Amongst the decreases of concentrations of other 
biomolecules (glutathione, NAD, etc.) during cy-ama- 
nitin poisoning in mice [ 131 a striking drop in serum 
protein was noticed, mainly in the albumin fraction, 
but also in other components, whose synthesis in liver 
seemed to be impaired by the poison [ 1 l] . 
4. Mechanism of toxic action 
As an approach to the study of the mechanism of 
ol-amanitin action, Fiume and Laschi [ 141 investigated 
the morphological lesions occurring in mouse liver and 
kidneys a few hours after toxin administration. They 
found that the targets of the toxic action of a-amani- 
tin are the nuclei, which within 1 hr after injection of 
OH NH2 OH 
OH OH OH 
H NH2 OH 
OH OH H 
H NH2 OH 
the toxin looked vesicle-like. Electron microscopic 
studies of mouse hepatocytes have confirmed that the 
first cellular organelle to show lesions after injection 
of o-amanitin is the nucleus [ 141 . Changes in cyto- 
plasmic organelles appear much later. The most 
striking and precocious lesions in the nucleic are ob- 
served in the nucleoli. A few minutes after the injec- 
tion of cy-amanitin, they break up and their fibrillar 
and granular components segregate [121. Another 
striking and early ultrastructural lesion is the conden- 
sation of chromatin, which causes the vesicle-like as- 
pect of the nuclei of the liver and of the kidneys in 
histological sections. The finding of chromatin con- 
densation in liver and kidney nuclei led to a study of 
the action of cy-amanitin on the loops of lampbrush 
chromosomes. a-Amanitin was found to produce a 
retraction of normal loops in the oocytes of Triturus 
&status carnifex [ 1.51. a-Amanitin also causes a 
shrinkage of puffs of giant chromosomes in salivary 
glands of Chironomus larvae [ 161. 
In the mouse kidneys a-amanitin affects only the 
cells of the proximal convoluted tubules [ 121. This 
finding led to the hypothesis that kidney damage is 
due to reabsorption in these tubules of ol-amanitin 
from the glomerular filtrate. Confirmation of this 
2 
Volume 8, number 1 FEBS LETTERS May 1970 
hypothesis was provided by experiments with a con- 
jugate of /I-amanitin (Ib) with rabbit serum albumin 
[5] which is filtered through the glomeruli only in 
minute quantities. After conjugation /3-amanitin 
toxicity was increased more than ten times for the 
liver [5] but was completely lost for the kidneys [ 121 . 
In rat hepatocytes, which are very resistant to 
cY-amanitin [lo] , the toxin produces lesions similar in 
appearance, in rapidity of onset and in severity to 
those in mouse liver cells, but which in contrast regress 
and disappear within 24 hr [ 121 . Unlike hepatocytes 
rat renal cells, even after injection of very high doses 
of a-amanitin, never show any lesions. This finding 
has been explained by suggesting that the cells of rat 
renal proximal tubules, in contrast to those of the 
mouse, do not have the capacity to reabsorb amanitin 
from the glomerular filtrate. Therefore these cells are 
not damaged and there is a rapid elimination of ama- 
nitin with the urine and a consequent rapid fall of the 
blood level. This explains the quick recovery of the 
nuclear lesions in liver cells and the resistance of the 
rat to amanitin. 
The action of cu-amanitin has also been studied in 
cultures of carcinomatous cells of the KB-Eagle line and 
in primary cultures of human amniotic cells [ 171. 
o-Amanitin kills these cells when its concentration in 
the medium reaches 2 pg/ml. Here also the first mor- 
phological lesion is at the level of the nuclei where 
fragmentation of nucleoli was observed. 
cu-Amanitin was found not to inhibit the multipli- 
cation of three species of bacteria (Escherichia coli, 
Staphylococcus aureus and Bacillus sub tilis) nor the 
replication of two RNA viruses (Poliovirus type 2 and 
parainfluenza virus type 3) and two DNA viruses (vac- 
cinia virus and the virus causing bovine infective rhino- 
tracheitis) [ 171 . 
After having identified one site of cytopathic 
attack of o-amanitin in the nucleus, the first step in 
an attempt to identify the underlying biochemical 
lesion was to determine the protein, DNA and RNA 
contents of the nuclei isolated from mouse hepato- 
cytes after injection of ol-amanitin [ 181. It was found 
that while the DNA and protein contents were un- 
changed even 24 hr after o-amanitin injection the 
nuclear RNA was decreased significantly after only 1 
hr. A study of the action of cr-amanitin on RNA 
synthesis in mouse liver showed a 50% inhibition 
of the incorporation of 14C-orotic acid into RNA 30 
min after the injection of 1.5 MLD [ 191. Consequent- 
ly the effect of cr-amanitin on the two RNA-polymerase 
reactions described in isolated liver nuclei by Widnell 
and Tata [20] was studied. One of them is activated 
by Mg*+ and produces an RNA of ribosomal type, the 
other one is activated by Mn*+ and a high concentra- 
tion of ammonium sulphate and produces DNA-like 
RNA [21,22] The first reaction is localized chiefly 
in the nucleoli, the second in the nucleoplasm [22, 
231. The Mn*+-ammonium sulphate-activated RNA- 
polymerase is strongly impaired in liver nuclei isolated 
from mice poisoned with cr-amanitin and the same 
reaction is inhibited by 8% when a-amanitin at a 
concentration of 1.5 X 10e8 M is added in vitro to 
nuclei from normal mouse hepatocytes. The MS*‘- 
activated RNA-polymerase is only slightly affected by 
cw-amanitin either administered to mice or added in 
vitro. The slight inhibition of this reaction by 10e8 M 
cu-amanitin does not increase even when the concen- 
tration is increased lOOO-fold. The finding that (Y- 
amanitin only inhibits the Mn*+-ammonium sulphate - 
activated RNA-polymerase [ 191 suggested that it 
does not act by binding to DNA and anticipated a 
specific lack of DNA-like RNA in the liver of o-ama- 
nitin-poisoned mice (provided this enzyme makes the 
same type of RNA in vivo as in vitro). Subsequently 
the action of a-amanitin on RNA polymerase solubi- 
lized from rat liver nuclei was studied (24-261 and 
it was found that the solubilized RNA-polymerase is 
inhibited to the same degree as the Mn*+-ammonium 
sulphate-activated RNA-polymerase in isolated nuclei. 
Since the soluble enzyme, deprived of its deoxyribo- 
nucleo-protein template, requires for its activity the 
addition of DNA, it was possible to demonstrate by 
increasing the concentration of DNA or of the enzyme 
that cy-amanitin exerts its inhibitory effect by binding 
to the enzyme and not to DNA. This mode of action 
resembles that of rifamycins on bacterial RNA-poly- 
merase [27,28]. In contrast to a-amanitin rifamycins 
do not inhibit mammalian RNA-polymerase [29]. On 
the other hand a-amanitin was found completely in- 
effective on bacterial RNA-polymerase [24,26, 301 
and on the RNA-polymerase of vaccinia-virus [3 l] . 
These results are consistent with the findings that 
o-amanitin has no effect on bacterial growth nor on 
vaccinia-virus replication [ 171 and indicate that the 
toxin is a specific inhibitor of RNA-polymerase of 
eukaryotic organisms. Interestingly the nontoxic 
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“aldo-amanitin” [9] has no effect on RNA-polymerase 
solubilized from rat liver nuclei [32]. 
Meanwhile Roeder and Rutter isolated several 
distinct RNA-polymerase activities from nuclei of 
eukaryotic cells [33] From rat liver nuclei these 
authors solubilized two RNA polymerase activities 
[I and II). Polymerase II requires for its action a Mn2+/ 
Mg2+ ratio and an ionic strength higher than does po- 
lymerase I. Polymerase I resides in the nucleolus and 
polymerase II in the nucleoplasm [34]. Probably these 
solubilized enzymes correspond to the two RNA- 
polymerase reactions of isolated nuclei [33], polymer- 
ase II being more easily solubilized than is polymerase 
I. In the experiments reported above, where the in- 
hibitory effect of cY-amanitin on solubilized RNA- 
polymerase was detected [24-261, the methods for 
solubilization [3.5,36] used very probably only 
solubilized polymerase II [33] . 
Recently it was found [37, 381 that o-amanitin 
strongly inhibits the RNA polymerase of nucleoplasm 
(polymerase II) and does not affect the enzyme of 
nucleoli (polymerase I). These results fit in with the 
previous finding of Stirpe and Fiume [ 191 on the two 
RNA-polymerase reactions in isolated nuclei and sub- 
stantiate the difference between polymerase activity 
in nucleoli and in the extranucleolar region of the liver 
cell nucleus. A selective inhibition by a-amanitin was 
observed also by Kedinger et al. [30], who found that 
this cyclopeptide inhibits only one of the two RNA- 
polymerases which they succeeded in isolating from 
calf thymus nuclei. 
Also RNA-polymerase from yeast, which is resistant 
to rifamycin, is completely inhibited by ol-amanitin, 
although the amount of toxic peptide required is about 
100 times higher (ca. 500 molecules per molecule of 
polymerase) than for the mammalian enzymes [39] . 
In the light of the new observations the decrease 
in protein content of the blood of cw-amanitin poisoned 
animals [ 1 I] can be explained as a consequence of the 
inhibition of RNA synthesis. 
As far as the mechanism of inhibitory action of 
ol-amanitin on the extranucleolar RNA-polymerase is 
concerned the only thing known up to now is that 
ol-amanitin inhibits the elongation step of transcription 
since its addition after start of polymerization does 
not modify the extent of inhibition [24-26, 301. The 
effect of the toxin on the initiation step is not yet 
known. 
4 
As a specific inhibitor of only one of the enzymes 
cy-amanitin will make it possible to differentiate the 
functions of the two RNA-polymerases present in 
mammalian nuclei. Therefore it will be an extremely 
useful tool in biological research. 
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